Research ArticleArticles on Covid-19
Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization?
CARSTEN NIEDER, ELLINOR C. HAUKLAND, BARD MANNSAKER and ROSALBA YOBUTA
In Vivo January 2021, 35 (1) 649-652; DOI: https://doi.org/10.21873/invivo.12304
CARSTEN NIEDER
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
ELLINOR C. HAUKLAND
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
BARD MANNSAKER
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
ROSALBA YOBUTA
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
In this issue
In Vivo
Vol. 35, Issue 1
January-February 2021
Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization?
CARSTEN NIEDER, ELLINOR C. HAUKLAND, BARD MANNSAKER, ROSALBA YOBUTA
In Vivo Jan 2021, 35 (1) 649-652; DOI: 10.21873/invivo.12304
Jump to section
Related Articles
- No related articles found.
Cited By...
- Independent Validation of a Risk Stratification Model Predicting Survival in Elderly Patients Irradiated for Bone Metastases
- Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review
- Symptom Burden in Patients Treated With Palliative Radiotherapy Before and During the COVID-19 Pandemic